Hangzhou Sunstone Technology Co., Ltd.

Manufacturer from China
Active Member
3 Years
Home / Products / Intestinal Stents /

Avoid Secondary Surgery Biodegradable Intestinal Bypass Stents BIS24-HB

Contact Now
Hangzhou Sunstone Technology Co., Ltd.
City:hangzhou
Country/Region:china
Contact Person:MsShen
Contact Now

Avoid Secondary Surgery Biodegradable Intestinal Bypass Stents BIS24-HB

Ask Latest Price
Video Channel
Brand Name :Biodegradable intestinal bypass stent
Model Number :BBS-S22, BBS-S24, BBS-S26
Certification :ISO13485
Place of Origin :Made in China
Price :Negotiation
Packaging Details :10 pcs/box, 6 boxes/carton
Delivery Time :7-10days (in stock); Negotiation(out of stock)
Supply Ability :80,000 pcs/month
Payment Terms :TT, L/C
Product use :Applicable for bowel bypass surgery
Product highlights :It is the first medical device in the world to protect the anastomotic stoma of low rectal cancer from stoma and reposition surgery. It can disintegrate and excrete from the body within 30 days.
Device classification :[CN] Class II
Material :PGA, barium sulfate
Specification description :Different specifications represent the maximum diameters of anastomotic stents of 22 mm, 24 mm……38 mm
Storage conditions :The product shall be stored in an environment that is cool, dry, well-ventilated, clean with a relative humidity of not more than 80% and free of corrosive gases to avoid prolonged exposure to elevated temperatures. Do not expose the device to an environme
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

[Avoid secondary surgery] Biodegradable Intestinal Bypass Stents BIS24-HB

Product Spectification:

Instructions Create an ileal incision 10 cm-15 cm from the ileocecal junction, place a product with appropriate size, and finally perform suture. Then place a drainage tube in the incision 10 cm proximal to the anastomosis. See the IFU for details.
Product advantages Effective prevention of anastomotic leakage;
It can avoid artificial anus indwelling and secondary operation;
Short treatment duration (2-4 weeks)
Within 4 weeks after surgery, the product can gradually disintegrate in the intestinal tract and excrete from the body, without residual foreign matters;
The product contains barium sulfate, which can be developed under X-ray, so its disintegration process is allowed to be dynamically tracked;
The physical and psychological trauma of the patients is significantly reduced.
Product structure and composition One-piece anastomosis stent
Precautions The product is for single use; it is not designed to be used in case of damaged package.
The product must not be used by unskilled or untrained personnel.
It is contraindicated in patients requiring two or more intestinal anastomoses.
Shelf life 2 years

Features:

1. It operate easily, conforms to physiology, disintegrates on time, and effectively avoids complications;

2. After two weeks of anastomosis, it gradually began to disintegrate in the intestine, and was excreted with feces within four weeks, leaving no foreign matters inside;

3. Avoiding the anal fistula indwelled and the secondary surgery.

Avoid Secondary Surgery Biodegradable Intestinal Bypass Stents BIS24-HB

Company Profile:

Hangzhou Sunstone Technology Co., Ltd, was established in 2005, is a manufacturing enterprise dedicated to the R&D and sales of innovative medical devices. The enterprise park covers an area of more than 7,000 square meters, and the enterprise assets exceed 30 million US dollars. The company is located in Hangzhou, China, with a production and office area of 20,000 square meters, of which the ISO 8 class cleanroom exceeds 1,000 square meters and the ISO 7 class cleanroom exceeds 500 square meters. Sunstone Technology is the first national high-tech enterprise dedicated to the research and development of absorbable medical consumables in Zhejiang Province, China. It has obtained the qualification of high-tech enterprise research and development center of Zhejiang Province Science and Technology Department of Innovation Medical Devices. Several of the unique medical devices we have developed have applied for Chinese and international patents. These projects are in different stages of research and development, some of which have entered the stage of registration and approval in China, and some in the stage of EU CE certification.

Inquiry Cart 0